Clinical Research Forum named the BIOS CTCC study Early Outpatient COVID-19 Plasma Treatment Research Study (CSSC-004) one of the Top 10 2023 Clinical Research Achievement Awardees. The Clinical Research Achievement Awards is sponsored by the Clinical Research Forum, and it honors those who demonstrate a commitment to excellence and innovation in clinical research. This awards…
The Early Outpatient COVID-19 Plasma Treatment Research Study (CSSC-004) has been named a finalist for the 2023 Clinical Research Achievement Awards. The Clinical Research Achievement Awards is sponsored by the Clinical Research Forum, and it honors those who demonstrate a commitment to excellence and innovation in clinical research. This awards program seeks to recognize research…
The Johns Hopkins University Division of Brain Injury Outcomes (BIOS) is pleased to announce the 2022 recipient of the Ann Dana Kusch Predoctoral Fellowship in Clinical Research and Innovation: Paul Ryu. Funding to establish the fellowship was awarded in late 2020 by the Kusch and Molbert families in honor of their mother, Ann Dana Kusch,…
The Early Outpatient COVID-19 Plasma Treatment Research Study (CSSC-004) had its final results published in The New England Journal of Medicine on March 30th, 2022. The study was led by researchers at Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of Public Health with support and coordination from BIOS. The primary outcome data show…
David Newman-Toker, MD, PhD, director of JHU’s Division of Neuro-Visual and Vestibular Disorders and a BIOS faculty member, was awarded the David Robinson Professorship in Vestibular Neurology. With this research-focused professorship, Newman-Toker plans to continue developing his tech-driven system to help diagnose dizzy patients. Dizziness can be deceptively benign, as it can be a symptom…
“I’m going to tell the story of the development of the Division of Brain Injury Outcomes into an academic research organization,” began BIOS director Daniel Hanley, MD, to a virtual audience. “This is more of an anecdotal talk, and for those of you who are disappointed by not having enough data, I apologize.” Hanley gave…
Attendees of the European Stroke Organisation Conference this month had a chance to learn about the OPTIMISTmain trial from its principal investigator, Victor Urrutia, MD. Urrutia is an associate professor of neurology at the Johns Hopkins University School of Medicine and director of the Johns Hopkins Hospital Comprehensive Stroke Center. He presented an e-poster on…
Earlier this year, the machine learning-based medical imaging solution that Johns Hopkins University’s BIOS team helped develop was chosen as an honoree in the Fast Company 2021 World Changing Ideas Awards in the AI and data category. This imaging solution was created via a collaboration of the BIOS Neuroimaging Center (BIONIC) team, Quantiphi, and Google…
The Johns Hopkins University Division of Brain Injury Outcomes (BIOS) is pleased to announce the inaugural recipients of the Ann Dana Kusch Predoctoral Fellowship in Clinical Research and Innovation: Shannon Hillery and Daniel Amirault. Funding to establish the fellowship was awarded in late 2020 by the Kusch and Molbert families in honor of their mother, Ann…
Daniel Hanley, MD, BIOS division director, and Issam Awad, MD, director of neurovascular surgery at UChicago Medicine, joined the November 2019 episode of the Neurocritical Care Society Podcast to discuss the MISTIE III trial with podcast host Fawaz Al-Mufti, MD. The trial results were recently published in the article, “Efficacy and safety of minimally invasive…
Clinical Research Forum named the BIOS CTCC study Early Outpatient COVID-19 Plasma Treatment Research Study (CSSC-004) one of the Top 10 2023 Clinical Research Achievement Awardees. The Clinical Research Achievement Awards is sponsored by the Clinical Research Forum, and it honors those who demonstrate a commitment to excellence and innovation in clinical research. This awards…
The Early Outpatient COVID-19 Plasma Treatment Research Study (CSSC-004) has been named a finalist for the 2023 Clinical Research Achievement Awards. The Clinical Research Achievement Awards is sponsored by the Clinical Research Forum, and it honors those who demonstrate a commitment to excellence and innovation in clinical research. This awards program seeks to recognize research…
The Johns Hopkins University Division of Brain Injury Outcomes (BIOS) is pleased to announce the 2022 recipient of the Ann Dana Kusch Predoctoral Fellowship in Clinical Research and Innovation: Paul Ryu. Funding to establish the fellowship was awarded in late 2020 by the Kusch and Molbert families in honor of their mother, Ann Dana Kusch,…
David Newman-Toker, MD, PhD, director of JHU’s Division of Neuro-Visual and Vestibular Disorders and a BIOS faculty member, was awarded the David Robinson Professorship in Vestibular Neurology. With this research-focused professorship, Newman-Toker plans to continue developing his tech-driven system to help diagnose dizzy patients. Dizziness can be deceptively benign, as it can be a symptom…
“I’m going to tell the story of the development of the Division of Brain Injury Outcomes into an academic research organization,” began BIOS director Daniel Hanley, MD, to a virtual audience. “This is more of an anecdotal talk, and for those of you who are disappointed by not having enough data, I apologize.” Hanley gave…
The Johns Hopkins University Division of Brain Injury Outcomes (BIOS) is pleased to announce the inaugural recipients of the Ann Dana Kusch Predoctoral Fellowship in Clinical Research and Innovation: Shannon Hillery and Daniel Amirault. Funding to establish the fellowship was awarded in late 2020 by the Kusch and Molbert families in honor of their mother, Ann…
Daniel Hanley, MD, BIOS division director, and Issam Awad, MD, director of neurovascular surgery at UChicago Medicine, joined the November 2019 episode of the Neurocritical Care Society Podcast to discuss the MISTIE III trial with podcast host Fawaz Al-Mufti, MD. The trial results were recently published in the article, “Efficacy and safety of minimally invasive…